The current status of brachytherapy in Europe − a GEC-ESTRO Brachy-HERO survey
File(s)1-s2.0-S2405630824001605-main.pdf (1.09 MB)
Published version
Author(s)
Type
Journal Article
Abstract
A survey regarding utilisation of brachytherapy was distributed to European brachytherapy professionals. Eighty replies from 26 countries were received, two of which were outside Europe. The replies showed that brachytherapy is still widely used. The main indications for brachytherapy are gynaecological and prostate cancer, with >80 % of the responding countries performing brachytherapy for these indications. There is on average one brachytherapy centre per 0.8 million inhabitants, ranging from 0.4 per million to 2.3 per million inhabitants. The organisation of brachytherapy on national levels also varies from country to country, with less than half of the countries having a central brachytherapy registry. All in all, the survey shows that brachytherapy still plays a role on modern radiotherapy, but the field could benefit from a stronger collaboration both nationally and internationally.
Date Issued
2025-01
Date Acceptance
2024-10-30
Citation
Clinical and Translational Radiation Oncology, 2025, 50
ISSN
2405-6308
Publisher
Elsevier
Journal / Book Title
Clinical and Translational Radiation Oncology
Volume
50
Copyright Statement
© 2024 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Identifier
http://dx.doi.org/10.1016/j.ctro.2024.100883
Publication Status
Published
Article Number
100883
Date Publish Online
2024-11-02